Dyne Therapeutics, Inc.
DYN
$18.29
-$0.37-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 24.14% | 0.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.96% | -1.64% | |||
| Operating Income | -1.96% | 1.64% | |||
| Income Before Tax | -3.62% | 2.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.62% | 2.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.62% | 2.54% | |||
| EBIT | -1.96% | 1.64% | |||
| EBITDA | -1.97% | 1.66% | |||
| EPS Basic | 0.46% | 21.74% | |||
| Normalized Basic EPS | 0.44% | 21.73% | |||
| EPS Diluted | 0.46% | 21.74% | |||
| Normalized Diluted EPS | 0.44% | 21.73% | |||
| Average Basic Shares Outstanding | 4.10% | 24.53% | |||
| Average Diluted Shares Outstanding | 4.10% | 24.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||